Consolidated Balance Sheets - USD ($)	Mar. 31, 2025	Dec. 31, 2024
CURRENT ASSETS:
Cash	$ 36,544	$ 3,629
Note receivable, net		105,326
Assets from discontinued operations	23,618	577,581
TOTAL ASSETS	60,162	686,536
CURRENT LIABILITIES:
Accounts payable and accrued liabilities	37,269	26,381
Accrued compensation		56,666
Due to related parties	7,326	826
Notes payable	216,960	216,960
Accrued interest	65,762	14,810
Derivative liability	526,033	510,154
Liabilities from discontinued operations	26,161	26,161
Total Current Liabilities	1,346,464	1,243,911
Total Liabilities	1,346,464	1,243,911
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ DEFICIT:
Series A Preferred stock, 200,000 shares authorized, $0.001 par value; 100,000 and 100,000 issued and outstanding, respectively	100	100
Common stock, 2,499,900,000 shares authorized, $0.001 par value; 1,047,852 and 1,047,852 issued and outstanding, respectively	1,048	1,048
Additional paid-in capital	2,501,362	2,501,362
Stock payable	36,130	36,130
Accumulated deficit	(3,824,942)	(3,096,015)
Total Stockholders’ Deficit	(1,286,302)	(557,375)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	60,162	686,536
Related Party [Member]
CURRENT LIABILITIES:
Convertible notes payable	74,501	74,501
Nonrelated Party [Member]
CURRENT LIABILITIES:
Convertible notes payable	$ 392,452	$ 317,452